Novel Psychoactive Substances: Classification, Pharmacology and Toxicology provides readers with background on the classification, detection, supply and availability of novel psychoactive substances, otherwise known as "legal highs." This book also covers individual classes of novel psychoactive substances that have recently emerged onto the recreational drug scene and provides an overview of the pharmacology of the substance followed by a discussion of the acute and chronic harm or toxicity associated with the substance. Written by international experts in the field, this multi-authored book is a valuable reference for scientists, clinicians, academics, and regulatory and law enforcement professionals. - Includes chapters written by international experts in the field. - Provides a comprehensive look at the classification, detection, availability and supply of novel psychoactive substances, in addition to the pharmacology and toxicology associated with the substance. - Offers a single source for all interested parties working in this area, including scientists, academics, clinicians, law enforcement and regulatory agencies. - Provides a full treatment of novel psychoactive substances that have recently emerged onto the recreational drug scene including mephedrone and the synthetic cannabinoid receptors in 'spice' / 'K2'.
This volume is designed to feature the pharmacology of new psychoactive substances, legislative aspects, information exchange including epidemiology, and clinical, forensic, and analytical toxicology in order to facilitate the understanding of this complex and rapidly developing phenomenon.
This volume brings together the latest basic and clinical research examining the effects and underlying mechanisms of psychedelic drugs. Examples of drugs within this group include LSD, psilocybin, and mescaline. Despite their structural differences, these compounds produce remarkably similar experiences in humans and share a common mechanism of action. Commonalities among the substances in this family are addressed both at the clinical and phenomenological level and at the basic neurobiological mechanism level. To the extent possible, contributions relate the clinical and preclinical findings to one another across species. The volume addresses both the risks associated with the use of these drugs and the potential medical benefits that might be associated with these and related compounds.
Miller takes readers on an eye-opening tour of psychotropic drugs, describing the various kinds, how they were discovered and developed, and how they have played multiple roles in virtually every culture.
Incorporating the latest developments in pharmacology and therapy, this fully revised Second Edition is an ideal quick reference for those who prescribe psychotrophic drugs for young people. New and notable features include: discussions of new drugs and health supplements; revised diagnostic terminology that accords with current DSM-IV nomenclature; reports on anti-epileptic medications; guidelines for the appropriate use of psychoactive medications; and instruction on the monitoring of physical, behavioral, and cognitive effects of various drugs. The handy spiral format makes the book easy to use.
“A well-founded and presented description of the integral role that psychoactive substances played in ancient societies. . . . A unique addition to ancient history collections.”—Choice “Very informative, well referenced, and well illustrated.”—Latin American Antiquity “A diverse and interesting introduction to the evidence for psychoactive use in the past, including consideration of the physical techniques and interpretative methods for understanding these practices.”—Journal of Psychedelic Studies "This well-researched and fascinating volume not only demonstrates the important cultural role of psychoactive substances in ancient societies but also points the way to an emerging research field. The unveiling of the past history of drug use becomes a lesson for present-day society."--Jan G. Bruhn, founding editor, Journal of Ethnopharmacology "Presents a broad overview of drug plants and fermented beverages by using anthropological, ethnological, archaeological, iconographic, chemical, and botanical approaches. Essential reading."--Elisa Guerra Doce, author of Drugs in Prehistory: Archaeological Evidence of the Use of Psychoactive Substances in Europe Mind-altering substances have been used by humans for thousands of years. In fact, ancient societies sometimes encouraged the consumption of drugs. Focusing on the archaeological study of how various entheogens have been used in the past, this volume examines why humans have social and psychological needs for these substances. Contributors trace the long-term use of drugs in ancient cultures and highlight the ways they evolved from being sacred to recreational in more modern times. By analyzing evidence of these substances across a diverse range of ancient cultures, the contributors explore how and why past civilizations harvested, manufactured, and consumed drugs. Case studies examine the use of stimulants, narcotics, and depressants by hunter-gatherers who roamed Africa and Eurasia, prehistoric communities in North and South America, and Maya kings and queens. Offering perspectives from many different fields of study, contributors illustrate the wide variety of sources and techniques that can provide information about materials that are often invisible to archaeologists. They use advanced biomolecular procedures to identify alkaloids and resins on cups, pipes, and other artifacts. They interpret paintings on vases and discuss excavations of breweries and similar sites. Uncovering signs of drugs, including ayahuasca, peyote, ephedra, cannabis, tobacco, yaupon, vilca, and maize and molle beer, they explain how psychoactive substances were integral to interpersonal relationships, religious practices, and social cohesion in antiquity. Scott M. Fitzpatrick, professor of archaeology at the University of Oregon, is coeditor of Island Shores, Distant Pasts: Archaeological and Biological Approaches to the Pre-Columbian Settlement of the Caribbean. Contributors: Quetta Kaye | Victor D. Thompson | Thomas J. Pluckhahn | Sean Rafferty | Mark Merlin | Matt Sayre | Constantino Manuel Torres | Zuzana Chovanec | Jennifer A. Loughmiller-Newman | Justin Jennings | Daniel M. Seinfeld | Shannon Tushingham | Scott M. Fitzpatrick
Here is a broad overview of the central topics and issues in psychopharmacology, biological psychiatry and behavioral neurosciences, with information about developments in the field, including novel drugs and technologies. The more than 2000 entries are written by leading experts in pharmacology and psychiatry and comprise in-depth essays, illustrated with full-color figures, and are presented in a lucid style.
This incisive book offers an epidemiological study of road users’ consumption of psychoactive substances in Nigeria. It examines psychoactive drug screening and the use of driving simulators to evaluate skills impairment after drinking alcoholic beverages. Portable electronic digital screening devices such as “Oral Screen,” along with other screening devices were used to establish the prevalence of substances of abuse among road users in some selected cities in Nigeria. Blood, saliva, urine, and other biological fluids were screened. Skills impairment, characterized by unsafe driving actions based on the level of blood alcohol concentration (BAC), was evaluated using a driving simulator. The findings were validated by application of a Field Impairment Test (FIT) or modified clinical test of impairment. The implication of the results on everyday highway utilization and the best approach for research into screening for psychoactive drugs are highlighted, along with several recommendations to enhance highway safety.
As part of its scientific activities, the German Research Council on Smoking and Health regularly provides opportunities for scientists to discuss progress in the field of nicotine research. In this context, the Research Council sponsored a Satellite Symposium in Hamburg, June 28-30, 1990 entitled "Effects of Nicotine on Biological Systems". This meeting was held in conjunction with the XIth International Congress of Pharmacology in Amsterdam and follows the first Satellite Symposium on Nicotine which was convened in Brisbane, Australia in 1987. The aim of these conferences has been to discuss state of the art research on the pharmacology and toxicology of nicotine and its metabolites and to integrate this information to help define nicotinic actions on the central and peripheral nervous system as well as to evaluate health or behavioral effects associated with use of this alkaloid. Furthermore, at this conference, potential therapeutic benefits of nicotine for certain disease states were discussed. Smoking and the health effects of smoking were dealt with only as far as they could not be separated from the effects of nicotine. This volume contains the lectures presented at the symposium and illustrates that knowledge of nicotine has advanced considerably in recent years with regard to mechanisms of its actions. Despite such progress however, it is apparent that a' large number of questions remain unanswered, especially in the light of new insight into cellular and molecular mechanisms which can be affected by nicotine.
